India Pharmaceutical Industry Studied in New In-Demand Espicom Report Recently Published at

01 Feb 2013 • by Natalie Aster

LONDON – Assessed to be worth over USD 4.48 billion, the Indian pharmaceutical industry registers annual growth of 8-9 percent or more given the sustainable growth of demand for drugs in every corner of the world. Indian pharmaceutical companies are able to satisfy almost 70 percent of the domestic demand. Currently, there are over 18,000 registered drugs manufacturers in the country.

The sector’s performance is characterized by the increase in the number of acquisitions due to the intention of local companies to boost the market’s growth and to enhance their capacities. India-based pharmaceutical producers operate also in other countries’ markets, with the USA and Russia being the key purchasers of Indian medicines. South Africa is another prominent purchaser of Indian drugs. In 2011, Indian pharmaceutical exports to the country were evaluated at USD 310 million.

New market research report “The Indian Pharmaceutical Industry 2013: Coming of Age in a Global Market” drawn up by Espicom Business Intelligence offers a detailed review of the Indian pharmaceutical industry, besides offering valuable data on sales revenue, domestic, international and emerging markets, world exports and foreign acquisitions. The study delves deep in the industry competition offering detailed profiles of 20 top Indian companies covering their corporate strategies, manufacturing capabilities, key markets, R&D, product offerings, financial performance, etc.

Report Details:

The Indian Pharmaceutical Industry 2013: Coming of Age in a Global Market
Published: January, 2013
Pages: 164
Price: US$ 1,390.00

More Topical Market Research Reports by Espicom are Available:

More new market research reports by the publisher can be found at Espicom page.


MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970